Brought to you by 
Third Wave licenses RiKen's gene markers
23 Jul 2002
Executive Summary
Third Wave Technologies (genetic variation analysis) has licensed exclusive worldwide rights (with the exception of Japan) to Rikagaku Kenkyusyo's (also known as RiKen and The Institute of Physical and Chemical Research) patents that cover more than 3,300 genetic markers within 200 genes that regulate drug metabolism.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Third Wave licenses RiKen's gene markers
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice